You are here

  • Home
  • Archive
  • Volume 15, Issue 3
  • Quadrivalent HPV vaccine administered to women who became pregnant during trials did not appear to adversely affect pregnancy outcome; however, use during pregnancy is not recommended

Article Text

Article menu
Download PDFPDF
Therapeutics
Combined analysis of randomised controlled trials
Quadrivalent HPV vaccine administered to women who became pregnant during trials did not appear to adversely affect pregnancy outcome; however, use during pregnancy is not recommended

https://doi.org/10.1136/ebm1066

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests KS-M is on the advisory board for OncoHealth Corp, a start-up company developing biomarkers for cervical cancer screening.